3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
申请人:The DuPont Merck Pharmaceutical Company
公开号:US05641782A1
公开(公告)日:1997-06-24
This invention relates to 3-Pyrimidinyl Bisnaphthalimides as Anticancer Agents and pharmaceutically acceptable salts thereof, of the formula: ##STR1## and processes for the preparation of such compounds, pharmaceutical composition containing such compounds, and methods of using such compounds to treat cancer, particularly solid tumor carcinomas, in mammals.